Pidotimune
Pidotimune Uses, Dosage, Side Effects, Food Interaction and all others data.
Pidotimune is a synthetic dipeptide with immunomodulatory properties.
Pidotimune modulates the immune system to induce an immune response against bacterial or viral pathogens
Trade Name | Pidotimune |
Generic | Pidotimod |
Pidotimod Other Names | Pidotimod |
Weight | 400mg, 800mg |
Type | Tablet |
Formula | C9H12N2O4S |
Weight | Average: 244.27 Monoisotopic: 244.051778048 |
Groups | Experimental |
Therapeutic Class | |
Manufacturer | La Renon Healthcare Pvt Ltd |
Available Country | India |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Pidotimune is a synthetic agent with immunomodulatory properties used in patients with documented cell-mediated immunosuppression to stimulate their immunity during lung and urinary tract infections.
For use as immunostimulant therapy for treatment of cell-mediated immunosuppression with respiratory or urinary infections .
Pidotimune is also used to associated treatment for these conditions: Recurrent Upper Respiratory Tract Infection, Immunostimulation
How Pidotimune works
Pidotimune inhibits tumor necrosis factor α (TNF-α) induced increases in extracellular signal-related kinase (ERK) phosphorylation . It also increases nuclear factor κB (NFκB) expression and translocation to the nucleus. It is these to modulatory effects on ERK and NFκB signalling which are thought to produce the increase in toll-like receptor expression seen with pidotimod. Pidotimune increase maturation of dendritic cells responsible for presenting antigens to naive Th-cells . It also appears to result in a greater population these cells diiferentiating to Th1 cells which are believed to mediate the immune response to pathogens like bacteria and viruses . Lastly, pidotimod appears to increase antigen-specific antibody titer and cytotoxic response with antigen exposure . The precise mechanism and timeline of events leading to these effects is unknown.
Elimination Route
Bioavailability of 45% .
Half Life
Half life of 4 h .
Elimination Route
95% of intravenous dose is eliminated in the urine as the parent compound .
Innovators Monograph
You find simplified version here Pidotimune